A Randomized Controlled Trial of Vildagliptin Versus Alogliptin: Effective Switch From Sitagliptin in Patients With Type 2 Diabetes

BACKGROUND: We investigated the effects of vildagliptin or alogliptin on blood glucose and hemoglobin A1c (HbA1c) in patients with type 2 diabetes inadequately controlled by sitagliptin. METHODS: In a single-center open-label trial, 35 patients with inadequate glycemic control on sitagliptin therapy...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Med Res
Asıl Yazarlar: Shigematsu, Erina, Yamakawa, Tadashi, Oba, Mari S., Suzuki, Jun, Nagakura, Jo, Kadonosono, Kazuaki, Terauchi, Yasuo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elmer Press 2017
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458653/
https://ncbi.nlm.nih.gov/pubmed/28611856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr3012w
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller